Karin Agerman

Nessuna posizione attualmente

51 anni

Health Technology

Consumer Services

Provenienza dei contatti di primo grado di Karin Agerman

Entità	Tipo di entità	Settore Industriale
COMBIGENE AB 9	Public Company	Pharmaceuticals: Major	9

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Karin Agerman tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Medical Specialties	Hilde Furberg	Corporate Officer/Principal
ENKAM Pharmaceuticals A/S ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark.	Medical Specialties	Morten Albrechtsen	Chief Executive Officer
Relation&Brand AB Relation&Brand AB Packaged SoftwareTechnology Services Relation&Brand AB develops and creates digital strategies, communications, and digital channels. It focuses on digital marketing, customer relationship management, and software. The company was founded by Nichlas Christer Spångberg in 1999 and is headquartered in Stockholm, Sweden.	Packaged Software	Louise Aspenberg	Corporate Officer/Principal
PCI BIOTECH HOLDING ASA	Biotechnology	Hilde Furberg	Director/Board Member
ABLIVA AB	Pharmaceuticals: Major	Jan Nilsson	Chief Executive Officer
BIOHEMP INTERNATIONAL, INC.	Pharmaceuticals: Major	Morten Albrechtsen	Director/Board Member
Q-Med AB Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden.	Medical Specialties	Gunilla Lundmark	Corporate Officer/Principal
Norma AS Norma AS TextilesProcess Industries Norma AS is engaged in the production and sale of safety systems and details for automobiles. Its operations are carried out through the following business segments: Car safety belts, Seat belt components, Car parts, Tooling, and Real estate activities. The company was founded in 1891 and is headquartered in Tallinn, Estonia.	Textiles	Morten Albrechtsen	Chairman
Copenhagen Business School	College/University	Morten Albrechtsen	Undergraduate Degree
University of Uppsala	College/University	Gunilla Lundmark Jonas Göran Ekblom Jan Nilsson	Masters Business Admin Corporate Officer/Principal Masters Business Admin
CALLIDITAS THERAPEUTICS AB	Pharmaceuticals: Major	Hilde Furberg	Director/Board Member
University of Copenhagen	College/University	Morten Albrechtsen	Doctorate Degree
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates	Morten Albrechtsen	Corporate Officer/Principal
University of Gothenburg	College/University	Jan Nilsson	Graduate Degree
IHM Business School AB	College/University	Anna Jönsson	Undergraduate Degree
EQL PHARMA AB	Pharmaceuticals: Generic	Anna Jönsson	Director of Finance/CFO
CanImGuide Therapeutics AB CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.	Pharmaceuticals: Major	Jan Nilsson	Director/Board Member
Pergamum AB Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.	Pharmaceuticals: Major	Jonas Göran Ekblom Jan Nilsson	Director/Board Member Corporate Officer/Principal
Baxter Medical AB		Hilde Furberg	Corporate Officer/Principal
BERGENBIO ASA	Pharmaceuticals: Major	Hilde Furberg	Chairman
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Pharmaceuticals: Major	Morten Albrechtsen	Chief Executive Officer
Accelerace Management A/S Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors.	Investment Managers	Morten Albrechtsen	Private Equity Investor
Appium Partners		Morten Albrechtsen	Chief Executive Officer
HERANTIS PHARMA OYJ	Pharmaceuticals: Major	Hilde Furberg	Director/Board Member
InnoCC ApS InnoCC ApS Medical SpecialtiesHealth Technology InnoCC ApS manufactures and develops medical devices for critical care units, which measure heart and lung function non-invasively on the basis of gas exchange in the lungs. It also develops devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. The company was founded in 2014 and is headquartered in Odense, Denmark.	Medical Specialties	Morten Albrechtsen	Chief Executive Officer
NociTech ApS NociTech ApS BiotechnologyHealth Technology NociTech ApS develops a novel pain assessment platform for pain treatment. It provides a test platform to quantify pain sensitivity in patients and profile new analgesic compounds under development. The company was founded by Lars Arendt-Nielsen on July 11, 2013 and is headquartered in Aalborg, Denmark.	Biotechnology	Morten Albrechtsen	Chief Executive Officer
JGN 1 3-12-2018 ApS JGN 1 3-12-2018 ApS Medical SpecialtiesHealth Technology JGN 1 3-12-2018 ApS develops and manufactures medical devices. Its products include Innocor, an instrument measuring cardiac output non-invasively; and AMIS 2000 The company is headquartered in Glamsbjerg, Denmark.	Medical Specialties	Morten Albrechtsen	Director/Board Member
Pulmotrace ApS Pulmotrace ApS Electronic Equipment/InstrumentsElectronic Technology Pulmotrace ApS produces sells, and services the product Innocor in EU, Canada, and United States. It develops a device that enables easier and more accurate measurement of lung function. The company is headquartered in Glamsbjerg, Denmark.	Electronic Equipment/Instruments	Morten Albrechtsen	Chairman
Blueprint Genetics Oy Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.	Biotechnology	Hilde Furberg	Chairman
SEDANA MEDICAL AB	Medical Specialties	Hilde Furberg	Director/Board Member
Panion Animal Health AB Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden.	Agricultural Commodities/Milling	Morten Albrechtsen Jan Nilsson	Director/Board Member Director/Board Member
Pluvia AS Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway.	Miscellaneous Commercial Services	Hilde Furberg	Director/Board Member
Bio-Me AS Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway.	Biotechnology	Hilde Furberg	Director/Board Member
J&J Future Invest AS J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency.	Real Estate Development	Hilde Furberg	Corporate Officer/Principal
Resursgruppen Ekonomi & Revision AB Resursgruppen Ekonomi & Revision AB Miscellaneous Commercial ServicesCommercial Services Part of Resursgruppen i Sverige AB, Resursgruppen Ekonomi & Revision AB provides accounting services. The company is based in Malmö, Sweden.	Miscellaneous Commercial Services	Anna Jönsson	Corporate Officer/Principal
Retipharma Ivs Retipharma Ivs Pharmaceuticals: MajorHealth Technology Retipharma Ivs develops drugs for eye disorders. The company is based in Copenhagen, Denmark.	Pharmaceuticals: Major	Morten Albrechtsen	Chairman
FLUOGUIDE A/S	Pharmaceuticals: Major	Morten Albrechtsen	Chief Executive Officer
Tappin AS		Hilde Furberg	Director/Board Member
Urbicum Ledningskonsult AB		Jan Nilsson	Director/Board Member
CarryGenes Therapeutics AB CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden.	Miscellaneous Commercial Services	Jan Nilsson	Director/Board Member
ONCOZENGE AB	Pharmaceuticals: Major	Hilde Furberg	Director/Board Member
Immodulate Pharma AB		Jan Nilsson	Director/Board Member
Neurovive Pharmaceutical AB		Jan Nilsson	Chief Executive Officer
Boehringer Ingelheim Danmark A/S Boehringer Ingelheim Danmark A/S Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Danmark A/S develops, produces, markets and sells pharmaceutical products. The company was founded in 1974 and is headquartered in Copenhagen, Denmark.	Pharmaceuticals: Major	Morten Albrechtsen	Corporate Officer/Principal
Wexotec Invest ApS		Morten Albrechtsen	Director/Board Member
Wear&Care ApS Wear&Care ApS Services to the Health IndustryHealth Services Wear&Care ApS develops and implements welfare technological solutions. It specializes in overcome of diseases which include dementia, sclerosis, parkinson, brain damage, cerebral paralysis, spinal diseases, and various physical handicaps. The company was founded by Martin Ettrup Hansen and Helle Thambo Andersen in 2012 and is headquartered in Odense, Denmark.	Services to the Health Industry	Morten Albrechtsen	Director/Board Member
Komplementar Appium Partners Ivs		Morten Albrechtsen	Chief Executive Officer
Webequ Ivs		Morten Albrechtsen	Chief Executive Officer